ClinicalCodes.org

An online clinical codes repository to improve validity and reproducibility of medical database research

Research article:

Examining variations in prescribing safety in UK general practice: a cross-sectional study using the Clinical Practice Research Datalink

Reference:

S Jill Stocks, Evangelos Kontopantelis, Artur Akbarov, Sarah Rodger, Anthony J Avery, Darren M Ashcroft(2015) Examining variations in prescribing safety in UK general practice: a cross-sectional study using the Clinical Practice Research Datalink. BMJ, doi: 10.1136/bmj.h5501

Link to fulltext article
Abstract
Study question What is the prevalence of different types of potentially hazardous prescribing in general practice in the United Kingdom, and what is the variation between practices? Methods A cross sectional study included all adult patients potentially at risk of a prescribing or monitoring error defined by a combination of diagnoses and prescriptions in 526 general practices contributing to the Clinical Practice Research Datalink (CPRD) up to 1 April 2013. Primary outcomes were the prevalence of potentially hazardous prescriptions of anticoagulants, anti-platelets, NSAIDs, β blockers, glitazones, metformin, digoxin, antipsychotics, combined hormonal contraceptives, and oestrogens and monitoring by blood test less frequently than recommended for patients with repeated prescriptions of angiotensin converting enzyme inhibitors and loop diuretics, amiodarone, methotrexate, lithium, or warfarin. Study answer and limitations 49 927 of 949 552 patients at risk triggered at least one prescribing indicator (5.26%, 95% confidence interval 5.21% to 5.30%) and 21 501 of 182 721 (11.8%, 11.6% to 11.9%) triggered at least one monitoring indicator. The prevalence of different types of potentially hazardous prescribing ranged from almost zero to 10.2%, and for inadequate monitoring ranged from 10.4% to 41.9%. Older patients and those prescribed multiple repeat medications had significantly higher risks of triggering a prescribing indicator whereas younger patients with fewer repeat prescriptions had significantly higher risk of triggering a monitoring indicator. There was high variation between practices for some indicators.Though prescribing safety indicators describe prescribing patterns that can increase the risk of harm to the patient and should generally be avoided, there will always be exceptions where the indicator is clinically justified. Furthermore there is the possibility that some information is not captured by CPRD for some practices—for example, INR results in patients receiving warfarin. What this study adds The high prevalence for certain indicators emphasises existing prescribing risks and the need for their appropriate consideration within primary care, particularly for older patients and those taking multiple medications. The high variation between practices indicates potential for improvement through targeted practice level intervention.
Author for correspondence
Jill Stocks
Email for correspondence
jill.stocks@manchester.ac.uk

Code list: res25: P5_heart_failure

26 codes in list

Code Coding system Description Entity type List name medcode
G1yz100 Read Rheumatic left ventricular failure diagnostic res25: P5_heart_failure 22262
G58..00 Read Heart failure diagnostic res25: P5_heart_failure 2062
G580.00 Read Congestive heart failure diagnostic res25: P5_heart_failure 398
G580000 Read Acute congestive heart failure diagnostic res25: P5_heart_failure 23707
G580100 Read Chronic congestive heart failure diagnostic res25: P5_heart_failure 32671
G580.11 Read Congestive cardiac failure diagnostic res25: P5_heart_failure 2906
G580.12 Read Right heart failure diagnostic res25: P5_heart_failure 10079
G580.13 Read Right ventricular failure diagnostic res25: P5_heart_failure 10154
G580.14 Read Biventricular failure diagnostic res25: P5_heart_failure 9524
G580200 Read Decompensated cardiac failure diagnostic res25: P5_heart_failure 27884
G580300 Read Compensated cardiac failure diagnostic res25: P5_heart_failure 11424
G580400 Read Congestive heart failure due to valvular disease diagnostic res25: P5_heart_failure 94870
G581.00 Read Left ventricular failure diagnostic res25: P5_heart_failure 884
G581000 Read Acute left ventricular failure diagnostic res25: P5_heart_failure 5255
G58..11 Read Cardiac failure diagnostic res25: P5_heart_failure 1223
G581.11 Read Asthma - cardiac diagnostic res25: P5_heart_failure 23481
G581.12 Read Pulmonary oedema - acute diagnostic res25: P5_heart_failure 43618
G581.13 Read Impaired left ventricular function diagnostic res25: P5_heart_failure 5942
G582.00 Read Acute heart failure diagnostic res25: P5_heart_failure 27964
G583.00 Read Heart failure with normal ejection fraction diagnostic res25: P5_heart_failure 101138
G583.11 Read HFNEF - heart failure with normal ejection fraction diagnostic res25: P5_heart_failure 101137
G583.12 Read Heart failure with preserved ejection fraction diagnostic res25: P5_heart_failure 106897
G584.00 Read Right ventricular failure diagnostic res25: P5_heart_failure 104275
G58z.00 Read Heart failure NOS diagnostic res25: P5_heart_failure 4024
G58z.11 Read Weak heart diagnostic res25: P5_heart_failure 12590
G58z.12 Read Cardiac failure NOS diagnostic res25: P5_heart_failure 17278

0 comments have been posted.

Please log in to leave a comment.